Interestingly, GS treatment of U266 cells also led to the downregulation of HMGB1, suggesting the involvement of HMGB1 in IL-6-mediated STAT3 signaling in MM cells (Figure 6C). Here, STAT3 is linked to Miyoshi myopathy.